The Study Everyone Cites Describes Two Patients

If you have searched for information about hair transplants for Black women, you have read pages written by hair transplant clinics.

Not content farms. Actual surgical practices, publishing detailed, confident, well-organised guidance about candidacy and outcomes, citing real studies. Some of it is accurate. All of it is written by people who profit if you book.

That is a different information environment from anything else this magazine has covered. When we wrote about wash frequency, the sources were dermatology journals with no stake in the answer. Here, the people producing nearly all the consumer-facing guidance are the people selling the procedure. So I went and read what they are citing.

What the foundational study actually contains

The paper that appears in almost every clinic page on this topic is Callender, Lawson and Onwudiwe, published in Dermatologic Surgery in 2014, on hair transplantation in central centrifugal cicatricial alopecia. It is cited as establishing that transplantation is safe and well tolerated for Black women with end-stage CCCA.

It describes two patients.

Not two hundred. Two African American women who had endured five to six years of progressive hair loss at the crown, treated with round punch grafting.

That is a case report. It is a legitimate and useful form of publication, and its findings appear to be real. What it cannot do is tell you how often this works, how often it fails, or what your odds are. Two successful outcomes establish that success is possible. They say nothing about frequency.

Somewhere between that paper and the page you are reading on a clinic website, "two patients did well" became "clinically proven for African American women."

The experts do not agree with each other

The thinness goes further than one study.

A 2025 survey published in Cureus asked dermatology residents and attending physicians how they actually treat CCCA. The paper opens by stating plainly that no established standard of care exists. The responses varied, and the authors attribute that partly to differing comfort levels among providers and to how often they see the later, burnt-out stage of the disease.

Even the prevalence is unsettled. A 2017 review in the Journal of Investigative Dermatology Symposium Proceedings puts CCCA at 2.7 to 5.7 percent of women of African descent. The 2025 survey paper cites an estimate of 15 percent. Those are not small disagreements about a rounding error. They differ by a factor of several, in the most common scarring hair loss condition affecting Black women.

This is what an under-researched condition looks like from the inside. Not absent knowledge, but thin and contested knowledge, sitting underneath marketing copy that reads as settled.

What actually determines candidacy

Here is the part worth knowing before you sit down with a surgeon, and it is genuinely well supported.

The disease has to be quiet. CCCA is an inflammatory scarring condition. Transplanting healthy follicles into a scalp where the inflammatory process is still active means the process destroys the new grafts too. The 2017 review states that surgical intervention should be reserved for patients with stable disease for nine to twelve months and an absence of inflammation confirmed histologically.

Confirmed how, matters. Not confirmed by the hair looking stable. Confirmed by scalp biopsy showing no inflammation. Those are different claims and only one of them is evidence.

Scar tissue is a harder place to grow hair. The same review names the central technical problem: grafts placed into scarred areas face a reduced survival rate, primarily because blood supply in that tissue is limited. This is not a complication that sometimes happens. It is the baseline condition of the procedure.

A test session should come first. The review recommends a test session along with the scalp biopsy to assess graft survival before committing to a full transplantation procedure. That is the single most useful sentence in this article. A small number of grafts, placed and monitored, tells you whether your scalp will hold them before you pay for a full session.

How to read a surgeon

Given that nearly every source has a financial interest, the useful skill is not finding a neutral article. It is evaluating the person in front of you.

A surgeon who is being straight with you will raise the biopsy without being asked, and will want to see the histology rather than take your word that things have settled. They will offer or recommend a test session. They will tell you that graft survival in scarred tissue is lower, before you ask. And if your disease is active, or you have been stable for four months rather than twelve, they will tell you to come back.

Someone who moves from consultation to booking without a biopsy, without discussing stability duration, and without mentioning reduced graft survival is not necessarily dishonest. But they are skipping the three things the literature says determine whether this works.

It is also worth asking a dermatologist who does not perform transplants whether you are a candidate. That is one of the few opinions available to you that is not attached to the sale.

What I am not saying

I am not saying do not do it. Two patients doing well is thin evidence, but it is evidence, and CCCA causes permanent loss that nothing currently reverses. For a woman whose disease has genuinely burnt out, this may be the only route back to hair at her crown, and the psychological weight of that is not a small consideration.

I am saying that the confidence of the marketing is not matched by the confidence of the research, and you should walk in knowing which is which.

If you are earlier than that, the more useful appointment is with a dermatologist rather than a surgeon. Traction alopecia is reversible in its early stage and permanent in its late one, and CCCA can sometimes be halted if it is caught before scarring completes. The window where medical treatment still works is the window worth protecting, and it closes quietly.

Nothing here is a substitute for a dermatologist who examines your actual scalp. That is the whole point of the article. The information available to you online was written by people who want your business, and the person you need is someone who does not.